EP7
EP7, licence 80075855: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ewyn Studios International
- NPN or DIN-HM
- 80075855
- Status
- Active licence
- Licence date
- 24 February 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 33.3 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 200.4 mg Potency : 25.0 % Anthocyanidins | 16.7 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 250.0 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine | 166.6 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 33.3 mg | Not calculated |
| trans-Resvératrol Source : Vitis vinifera - Fruit | 8.3 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 216.8 mg Potency : 85.0 % Proanthocyanidins | 54.2 mg | Not calculated |
| Pinus pinaster Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 216.8 mg Potency : 75.0 % Procyanidins | 54.2 mg | Not calculated |
Non-medicinal ingredients
Cétone de framboise, Gélatine, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant for the maintenance of good health. Used in Herbal Medicine as a capillary/blood vessel protectant. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80075855
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.